PHARMACOTHERAPY OF SYSTEMIC AUTOIMMUNE DISEASES IN CONDITIONS OF THE COVID-19 PANDEMIC: INNOVATIVE EXPERIMENTAL STUDY

Keywords: pharmacotherapy, evidence-based medicine, forensic pharmacy, evidence-based pharmacy, systemic autoimmune diseases, drugs, content analysis

Abstract

The article presents the results of an innovative experimental study of pharmacotherapy of systemic autoimmune diseases in a pandemic of coronavirus infection is a timely and socially oriented way. The methodology of conducting a content analysis based on the theoretical principles of pharmaceutical and medical law and its components. Author used the method of drug selection developed by the Department of Medical and Pharmaceutical Law, General and Clinical Pharmacy of the Kharkiv Medical Academy of Postgraduate Education. Content analysis was performed by dosage forms by grouping them using the Sturgess formula, followed by the construction of discrete series of variations and distribution polygon. Received data made possible to state, that in some circumstances, doctors have a choice of both drugs and dosage forms. However, the data obtained show a lack of balance between supply and demand for patients and physicians. The analysis allows to obtain a complete description of the balance of "supply and demand" between the range and types of dosage forms of drugs INN Silymarin ATC code A05BA03, that approved for use.

References

Hayduchok I.G., Shapovalova V.O., Shapovalov V.V., Shapovalov V.V. Control regime of antibacterial drugs for pharmacotherapy of coronavirus disease (COVID-19) among patients with dual disorders. An information letter about innovations Ukrmedpatentinform of the Ministry of Health of Ukraine. Kyiv: Ukrmedpatentinform of the Ministry of Health of Ukraine. 2020. N. 230–2020. 6 p.

Hayduchok I. G., Shapovalova V. O., Shapovalov V. V., Shapovalov V. V. Control regime of drugs for pharmacotherapy of coronavirus disease (COVID-19) among patients with systemic diseases. An information letter about innovations Ukrmedpatentinform of the Ministry of Health of Ukraine. K.: Ukrmedpatentinform of the Ministry of Health of Ukraine. 2020. N. 225 – 2020. 6 p.

Beketova TV, Blank LM, Lila AM. COVID-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab) // Rheumatology Science and Practice. 2019. Retrieved from https://rsp.mediar-press.net/rsp/article/view/2889?locale=ru_RU#

Hayduchok I. Pharmacotherapy of immunopathological syndromes among patients with systemic lupus erythematosus based on ABC/VEN analysis // Acta Scientific Medical Science. 2021. Vol. 5, Iss. 6. P. 67-73. DOI: 10.31080/ASMS2020.05.0925

Hayduchok I. G., Shapovalova V. O., Shapovalov (Jr.) V. V. Shapovalov V.V. Control regime of drugs for pharmacotherapy vasculitis of Shenlein-Genoch: An information letter about innovations Ukrmedpatentinform of the Ministry of Health of Ukraine. K.: Ukrmedpatentinform of the Ministry of Health of Ukraine, 2021. N. 64–2021. 7 p.

Yemchenko Y. O., Ishcheikin K. E., Kaidashev I. P. Analysis of the incidence and prevalence of psoriasis in Ukraine and Poltava region. Bulletin of VDNZU "Ukrainian Medical Dental Academy". 2014. Vol. 14, N. 3. P. 72–76.

Hayduchok I. G., Shapovalova V. O., Shapovalov V. V., Shapovalov V. V. Control regime of drugs for pharmacotherapy Rheumatoid arthritis. An information letter about innovations Ukrmedpatentinform of the Ministry of Health of Ukraine. Kyiv: Ukrmedpatentinform of the Ministry of Health of Ukraine. 2020. N. 36 –2021. 7 p.

Shapovalov (Jr.) V., Gudzenko A., Komar L. et al. Concerning the importance of forensic and pharmaceutical researches to improve patients’ accessibility to medicines. Pharmacia. 2017. Vol. 65, N. 2. P. 23–29.

Shapovalov V. Use of innovative technologies in pharmacotherapy with target nanotherapy on the principles of evidence-based medicine and pharmacy. Actual problems of medicine and pharmacy. 2020. Vol. 1, N 1-2. Retrieved from http://apmplmi.com

Davis J. Content analysis of efficacy descriptions on branded pharmaceutical websites. Journal of Medical Marketing. 2012. Vol.12, N. 4. Р. 211-220. DOI:10.1177/1745790412465425.

Hayduchok I. Pharmacotherapy of Systemic Vasculitis Combined with Cryoglobulinemic Syndrome using Pharmacoeconomic Approaches // Global Journal of Health Science. 2021. Vol. 13, N. 7. P. 78-88. DOI: 10.5539/gjhs.v13n7p78. Retrieved from https://doi.org/10.5539/gjhs.v13n7p78).

ATC-classification. Compendium on-line. Retrieved from http://www.compendium.com.ua/atc

Ministry of healthcare of Ukraine official site. Retrieved from http://www.moz.gov.ua

National list of basic medicines. – Resolution of the Cabinet of Ministers of Ukraine. 2009 March 25. N. 333. Retrieved from http://www.zakon4.rada.gov.ua

On approval of the twelfth issue of the State formulary of medicines and ensuring its availability. Order of the Ministry of Health of Ukraine. 2020 May 06. N. 1075. Retrieved from http://www.zakon4.rada.gov.ua

Shapovalova V. System of drugs circulation based on medical and pharmaceutical law. Actual problem of medicine and pharmacy. 2020. Vol. 1, N. 1-2. Retrieved from http://apmplmi.com

Shapovalova V.O., Zbrozhek S.I., Shapovalov V.V. (Jr.), Shapovalov V.V. Content analysis of pharmacies in Ukraine, which produce extemporaneous drugs. Public health. 2017. T.6, №3–4. P. 77–83. DOI: 10.22141/2306-2436.6.3.2017.123498

Shapovalova V.O. et al. Content analysis of alcohol circulation in healthcare facilities at the stage of budget procurement. Copyright N. 79456 (Ukrainian). Publ. 05/31/18

Gudzenko A.A., Osyntseva A.A., Shapovalova V.O. Content analysis of alcohol circulation by dosage forms and registration certificates. Copyright 79473 (Ukrainian). Publ. 06/01/18

Management Science for Health. Managing Medicines Selection. Managing Access to Medicines and Health Technologies. USA: Arlington, 2012. P. 16.1–16.15.

Parnes O. Autoimmune disease. The Lancet. 2018. N. 367. P. 389.

Anderson P.D., O'Donnell J. The Forensic Pharmacist. Drug Injury: Liability, Analysis, and Prevention. Hardcover. 2017. N 23. P. 761-770.

Takakubo K., Konttinen Y. Immune-regulatory mechanisms in systemic autoimmune and rheumatic diseases. Clin. Dev. Immunol. 2012. Vol. 37, N. 3. P. 341–346.

Shapovalov (Jr.) V. et al. Forensic and pharmaceutical study of the presence of a causal link between the degree of alcohol abuse and qualification level of the respondents. Pharmacia. 2017. Vol. 66, N. 3. P. 31–39.

Hayduchok I., Shapovalov V. Organizational and legal measures of state control of reforming and modernizing the health care on principles of pharmaceutical and medical law. Actual problems of medicine and pharmacy. 2020. Vol. 1, N. 1-2. Retrieved from http://apmplmi.com

Shapovalova V. A., Zbrozhek S. I., Shapovalov V. V, Shapovalov V. V. Forensic pharmacy: some risk factors in the formation of addictive health disorders. Acta Scientific Pharmaceutical Sciences. 2021. Vol. 4, N. 1. P. 7–12. DOI: 10.3180 / ASPS.2020.05.0651

Shapovalova V. A., Zbrozhek S. I., Shapovalov V. V, Shapovalov V. V. Organizational and legal evaluation of availability of medicines’ circulation for cancer patients. Pharmacia. 2018. Vol. 65, N. 2. P. 17-22.

Hsieh Hsiu-Fang, Shannon Sarah E. Three approaches to qualitative content analysis. ResearchGate. 2005. DOI:10.1177/1049732305276687. Retrieved from https://www.researchgate.net/publication/7561647_Three_Approaches_to_Qualitative_Content_Analysis

Davis J. Content analysis of efficacy descriptions on branded pharmaceutical websites. Journal of Medical Marketing. 2012. N.12 (4). Р. 211-220. DOI:10.1177/1745790412465425

Shapovalov (Jr.) V. et al. Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society. International Journal of Pharmaceutical Sciences Review and Research. 2018. Vol. 51, N. 18. P. 118–124.

Shapovalova V.O., Zbrozhek S.I., Shapоvalov (Jr.) V.V., Shapovalov V.V. Coronavirus disease pandemic 2019: growth of epidemic dangers. Acta scientific pharmaceutical sciences. 2020. Vol. 4, N. 7. P. 61–68.

Views:

98

Downloads:

69

Published
2021-06-19
Citations
How to Cite
Hayduchok, I. (2021). PHARMACOTHERAPY OF SYSTEMIC AUTOIMMUNE DISEASES IN CONDITIONS OF THE COVID-19 PANDEMIC: INNOVATIVE EXPERIMENTAL STUDY. Science Review, (3(38). https://doi.org/10.31435/rsglobal_sr/30072021/7619
Section
Medicine
Share